Home  >  Pharma People
Pharma People
+ Font Resize -

Gilead Sciences to appoint John C Martin as new chairman

Foster City, California
Saturday, December 16, 2017, 18:00 Hrs  [IST]

Gilead Sciences has announced that executive chairman John Martin, PhD will transition from his current role of executive chairman to chairman of the board of directors effective March 9, 2018. Dr. Martin was named Executive Chairman on March 10, 2016, when he was succeeded as CEO by John Milligan, PhD. Dr. Martin served as chief executive officer of Gilead from 1996 to 2016, having joined the company in 1990 as the vice president of research and development. During his time as CEO, he built the company's portfolio to 24 marketed products with annual revenues of more than $32 billion.

"John's scientific and business leadership has been notable for the development of Gilead's portfolio of HIV and viral hepatitis medicines and commitment to worldwide access for patients. We are all grateful that he will continue to help guide the company as chairman of the board," said Dr. Milligan, president and chief executive officer of Gilead.

 

Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
Chemspec_India-2018
IPE_2018_Banner_150X60
InnoPack-Pharma_150x60_2018
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
IPX_Logo_2018_150x60_web
CPHI18_banner_150x6
CPhI_China_150x60-2018
CPhI_Japan_150x60_2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
duphat_150x60
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |